Washington 340B laws

One Washington law names the 340B program. Here is what it does, who it applies to and where to read it.

Title 69 RCW (new chapter); chapter 43.71C RCW

A manufacturer, or a third party acting for one, may not deny, restrict or prohibit a 340B drug reaching a covered entity, a contract pharmacy or an authorized location, and may not require data as a condition. Federally qualified health centers and certain hospitals report their 340B figures, the use of savings included, to the Health Care Authority by April 1 each year; manufacturers report 340B units and discounts.

Bill
E2SSB 5981
Act
Laws of 2026, ch. 227
Session
2026
In effect
11 June 2026
Applies to
Drug manufacturers and third parties that act for them; federally qualified health centers and hospitals that are 340B covered entities
Limits
The covered entity report applies to federally qualified health centers and to hospitals under 42 U.S.C. 256b(a)(4)(L) to (O). Their filing fees may cover no more than 25 percent of the authority's reporting costs.
Enforcement
In a covered entity's suit a court may award a civil penalty of up to $5,000 a day for each violation. The Attorney General may enforce under the consumer protection act. A late report can be fined $1,000 a day after 30 days to correct it.

A manufacturer or a third party acting on behalf of a manufacturer may not, directly or indirectly, deny, restrict, or prohibit the acquisition of a 340B drug by, or delivery of a 340B drug to, a covered entity

From the law’s text

Plain-language summaries, not legal advice. Laws change, and court rulings on them are not covered here. Read the state’s own page before you rely on one.

See something missing or out of date? Tell us.